The aims of the present study were: (a) To analyse the mTOR pathway expression in tumoral and peritumoral tissue of HCC patients undergoing LT; (b) To correlate the mTOR pathway expression with histological features of HCC; (c) To explore whether mTOR over-expression modulates the risk of tumour recurrence after LT. Here, MTOR is linked to hepatocellular carcinoma.